Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. NVDA
3. SPCX
4. MU
5. LCO
6. KR
7. APGE
8. MSTR
9. ABBV
10. ICE

Go back to Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook

Guardant Health (GH) Tops Q4 EPS by 22c; Offers FY23 Revenue Guidance

February 23, 2023 4:36 PM EST

Guardant Health (NASDAQ: GH) reported Q4 EPS of ($1.17), $0.22 better than the analyst estimate of ($1.39). Revenue for the quarter came in at $126.9 million versus the consensus estimate of $123.71 million.

GUIDANCE:

Guardant Health sees FY2023 revenue of $525-540 million, versus the consensus of... More